Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
90,691,605
-
Shares change
-
-1,789,158
-
Total reported value, excl. options
-
$2,483,201,789
-
Value change
-
-$46,730,979
-
Put/Call ratio
-
34%
-
Number of buys
-
127
-
Number of sells
-
95
-
Price
-
$27.39
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2024
As of 30 Sep 2024 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 275 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 90,691,605 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, EARNEST PARTNERS LLC, Camber Capital Management LP, BANK OF AMERICA CORP /DE/, DISCIPLINED GROWTH INVESTORS INC /MN, and Artisan Partners Limited Partnership.
This table shows 275 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.